Toxicity of a 24-hour infusion of gemcitabine in biliary tract and pancreatic cancer: A pilot study

Cancer Investigation

Volumn 20, Issue 2, 2002, Pages 180-185

  Eckel, Florian ^a   Lersch, Christian ^a   Assmann, Gerald ^a   Schulte Frohlinde, Ewert ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

24 hr infusion; Biliary tract cancer; Gemcitabine; Pancreatic cancer; Prolonged infusion; Toxicity

Indexed keywords

FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTHENIA; BILIARY TRACT CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG INFUSION; DRUG SENSITIVITY; FEMALE; FEVER; HUMAN; INFLUENZA; MALE; MAXIMUM TOLERATED DOSE; MUCOSA INFLAMMATION; NEUTROPENIA; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; THROMBOCYTOPENIA;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BILIARY TRACT NEOPLASMS; DEOXYCYTIDINE; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; PROSTATIC NEOPLASMS;

EID: 0036196231     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120001144     Document Type: Article

References (25)

1. The role of chemotherapy and radiation in the management of biliary cancer: A review of the literature
2. Phase II trial of low-dose cyclophosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer
3. Chemotherapy in advanced pancreatic adenocarcinoma
4. Clinical and preclinical activity of 2′,2′-difluorodeoxycytidine (Gemcitabine)
5. Gemcitabine: Preclinical pharmacology and mechanisms of action
6. Preclinical in vivo activity of 2′,2′-difluorodeoxycytidine (Gemcitabine) against human head and neck cancer
7. Intratumoral pharmacokinetic analysis by 19F-magnetic resonance spectroscopy and cytostatic in vivo activity of gemcitabine (dFdC) in two small cell lung cancer xenografts
8. Schedule-dependent antitumor effect of gemcitabine in in vivo model system
9. Antitumor activity of prolonged as compared with Bolus Administration of 2′,2′-difluorodeoxycytidine in vivo against murine colon tumors
10. A phase I study of a 24 hour infusion of Gemcitabine in previously untreated patients with inoperable non-small-cell lung cancer
11. Saturation of 2′,2′-difluorodeoxycytidine 5′-triphosphate accumulation by mononuclear cells during a phase I trial of Gemcitabine
12. Phase I clinical trial of Gemcitabine given as an intravenous bolus on 5 consecutive days
13. Difluorodeoxycytidine (dFdC)-Gemcitabine: A phase I study
14. A phase I clinical, plasma, and cellular pharmacology study of Gemcitabine
15. Maximum-tolerated dose defined for single-agent Gemcitabine: A phase I dose-escalation study in chemotherapy - Naive patients with advanced non-small-cell lung cancer
16. More is better but... How is best: Are milligrams over hours better than grams over minutes? The case of Gemcitabine
17. Improvements in survival and clinical benefit with Gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
18. Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of Gemcitabine in patients with advanced biliary cancer
19. Prolonged infusion of Gemcitabine in stage IV breast cancer: A phase-I-study
20. A phase I trial of 72-Hour infusional gemcitabine in refractory genitourinary tumors using an accelerated titration design
21. Phase I dose-escalation trial of gemcitabine and cisplatin for advanced non-small-cell lung cancer: Usefulness of mathematic modeling to determine maximum-tolerable dose
22. Long-term results of endoscopic treatment of biliary duct obstruction due to pancreatic disease
23. Long-term outcome of patients with advanced klatskin tumors undergoing palliative endoscopic or percutaneous drainage
24. A 42-year-old man with hemolytic-uremic syndrome associated with gemcitabine therapy for adenocarcinoma of the liver
25. A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy